A Study on the Expression of BCR-ABL Transcript in Mixed Phenotype Acute Leukemia (MPAL) Cases Using the Reverse Transcriptase Polymerase Reaction Assay (RT-PCR) and its Correlation with Hematological Remission Status Post Initial Induction Therapy

<p><strong>Introduction</strong>: The MPAL comprise 2-5% of all acute leukemia. The present WHO 2008 classification has separated two groups in MPAL based on t(9;22) positivity and MLL rearrangement. <strong>Aims & Objectives</strong>: The aim of the present pilot study is to note the incidence of BCR-ABL transcript in MPAL cases using the RT-PCR assay and to correlate the status with hematological remission post induction. <strong>Materials & Methods</strong>: A total of 10 MPAL cases classified on Flow-cytometry based on the current WHO 2008 criteria were enrolled. In all the cases Bone marrow or peripheral blood sample in EDTA was processed for molecular studies and the RT-PCR reaction carried out using primers specific to the t (9;22) and t(4;11) translocation. The post induction check marrow slides were also reviewed. <strong>Results</strong>: Out of the total 10 MPAL cases, 7/10 (70%) were adult and 3/10 (30%) pediatric cases. A total of 4/10 (40%) cases showed positivity for the t(9;22) transcript and none for t (4;11). Of the 4 positive cases, 3/10(30%) were adult cases and 1/10(10%) pediatric case. The BCR-ABL transcript type in adult cases was b3a2 (p210) in 2/3 (66%) and e1a2 (p190) in 1/3 (33.3%) case. The single pediatric case was positive for b3a2 transcript. <strong>Discussion & Conclusion</strong>: All the 4 positive MPAL cases presented with high TLC and low platelet count (p<0.05). The positive cases also showed hematological remission at post induction check marrow (blasts<5%). This could partly be explained due to good response to the imatinib added to the treatment protocol.</p&gt

The influence of the terminal acceptor and oligomer length on the photovoltaic properties of A–D–A small molecule donors

Four new A–D–A small molecules (denoted as FG1–4) have been designed and synthesized. The compounds have cyclopentadithiophene-vinylene (CPDTV) oligomers of different lengths as the central donor core linked with different terminal acceptor units (3-ethylrhodanine or dicyanomethylene-3-ethylrhodanine). The effects that conjugation length and terminal acceptor units have on the optical and electrochemical properties were investigated. These small molecules were used as donors in conjunction with PC71BM as an acceptor in the bulk heterojunction active layer for the fabrication of solution-processed organic solar cells. Solvent vapor annealing treatment improved the crystallinity and the interpenetrating networks of donor and acceptor phases for exciton dissociation and charge transfer, thus leading to significant improvements in the overall power conversion efficiency (PCE) of the organic solar cells. The PCE values for the organic solar cells based on the optimized FG1:PC71BM, FG2:PC71BM, FG3:PC71BM and FG4:PC71BM active layer were 5.58%, 6.99%, 7.51% and 8.43%, respectively. These results indicate that an enhancement in the PCE of small molecule organic solar cells can be achieved by an increase in conjugation-length and variation of terminal acceptor units in the molecular backbone of small molecules and optimization of the crystallinity and nanoscale interpenetrating morphology by appropriate solvent vapor annealing treatment

Achieving Surgical, Obstetric, Trauma, and Anesthesia (SOTA) care for all in South Asia

South Asia is a demographically crucial, economically aspiring, and socio-culturally diverse region in the world. The region contributes to a large burden of surgically-treatable disease conditions. A large number of people in South Asia cannot access safe and affordable surgical, obstetric, trauma, and anesthesia (SOTA) care when in need. Yet, attention to the region in Global Surgery and Global Health is limited. Here, we assess the status of SOTA care in South Asia. We summarize the evidence on SOTA care indicators and planning. Region-wide, as well as country-specific challenges are highlighted. We also discuss potential directions—initiatives and innovations—toward addressing these challenges. Local partnerships, sustained research and advocacy efforts, and politics can be aligned with evidence-based policymaking and health planning to achieve equitable SOTA care access in the South Asian region under the South Asian Association for Regional Cooperation (SAARC)

INCIDENCE OF COMMON FUSION TRANSCRIPTS IN ADULT AND PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) CASES: EXPERIENCE OF A TERTIARY CARE RESEARCH INSTITUTE

<p><strong>Introduction</strong>: The incidence of common fusion transcripts in AML is 40-45%, but data from Indian sub-continent is limited. <strong>Aims & Objectives</strong>: The aim of the present study is to note the incidence of common fusion transcripts of AML1-ETO, PML-RARA and CBFβ-MYH11 in adult and pediatric AML cases. <strong>Materials & Methods</strong>: A total of 116 AML cases diagnosed on bone marrow, cytochemistry and Flow-cytometry over a period of 1.5 year were enrolled and bone marrow samples in EDTA were processed by Multiplex RT-PCR assay. <strong>Results</strong>: Of 116 cases, 96 (83%) were adult and 20 (17%) pediatric cases. A total of 39/116 (33.6%) cases showed positivity for fusion transcripts of which 28/96 (29.16%) were adult and 11/20 (55%) pediatric cases. Of the 28 positive adult cases, 14/96 (14.58%) were positive for AML1-ETO, 12/96 (12.5%) for PML-RARA and 2/96 (2.08%) for CBFβ-MYH11. In the 11 positive pediatric cases, 6/20 (30%) were positive for AML1-ETO, 3/20 (15%) for PML-RARA and 2/20 (10%) for CBFβ-MYH11. <strong>Discussion & Conclusion</strong>: The incidence of the common fusion transcripts in our pilot study is in accordance with that described in western studies. It is important to identify these transcripts as they provide useful prognostic information to the treating clinician.</p&gt

A 9.16% Power Conversion Efficiency Organic Solar Cell with a Porphyrin Conjugated Polymer Using a Nonfullerene Acceptor

A new low-molecular-weight porphyrin-based polymer, PPPyDPP, with pyridine-capped diketopyrrolopyrrole (DPP) has been synthesized, and its optical and electrochemical properties were investigated. The polymer is prepared with a low content of homocoupling units and gives a widely spread absorption from 400 to 900 nm with a narrow optical band gap of 1.46 eV. The highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) energy levels are respectively located at -5.27 and -3.78 eV, respectively. PPPyDPP was used as the electron donor, whereas [6,6]-phenyl-C-71-butyric acid methyl ester (PC71BM) and bis(rhodanine)indolo-[3,2-b]-carbazole (ICzRd(2)), a nonfullerene small molecule, were used as acceptors for the fabrication of solution-processed bulk heterojunction polymer solar cells. Overall power conversion efficiencies (PCEs) of 7.31 and 9.16% (record high for porphyrin-containing polymers) were obtained for PC71BM and ICzRd(2), respectively. A high V-oc of 1.01 V and a low E-loss of 0.45 eV may explain this new record

Hematological Evaluation of Primary Extra Nodal Versus Nodal NHL: A Study from North India

Primary extra nodal lymphomas (EN-NHL) are different from primary nodal non-Hodgkin’s lymphoma (N-NHL) and are comparatively less common. Hemogram findings and bone marrow involvement is less studied and very few reports are available in the literature. The present study is a retrospective analysis of bone marrow samples evaluated for staging of non-Hodgkin’s lymphoma. The age, sex distribution, clinical features, and site of presentation, hemogram findings, pattern of bone marrow involvement and grade of reticulin fibrosis was noted. These findings were compared with the type of non-Hodgkin’s lymphoma and prognostic information was determined. A total of 647 cases of NHL, which underwent bone marrow examination for staging, over a seven year period, were retrieved and analyzed for all hematological parameters. Prevalence of EN-NHL was 23.5% (152/647), while nodal NHL comprised 76.5% (495/647) of all NHL cases. 90.1% (137/152) cases of EN-NHL were adult patients, out of which 15.3% (21/137) cases showed bone marrow infiltration as compared to 89% (441/495) adult primary nodal NHL cases, of which 39% (175/441) showed bone marrow infiltration. 9.9% (15/152) cases of EN-NHL were pediatric patients, out of which 40% (6/15) showed bone marrow infiltration, while 10.9% (54/495) of nodal NHL cases were pediatric, of which 20.3% (11/54) showed bone marrow infiltration. Hemogram findings were not found useful in predicting bone marrow infiltration in both nodal as well as EN-NHL. 100% (6/6) of pediatric patients had high grade lymphoma as compared to 48% (9/21) of adult patients, showing bone marrow infiltration in EN-NHL group. Reticulin fibrosis also did not reveal relation with grading of NHL. Prognostically EN-NHL of stomach and central nervous system were found to be better than EN-NHL of other sites, as none of these cases showed bone marrow infiltration. EN-NHL can involve various sites and the prognosis depends upon the sites of disease as well as the type of NHL. Moreover, pediatric EN-NHL cases are likely to have poorer prognosis, due to increased risk of bone marrow involvement as compared to their counterparts having primary nodal NHL. Bone marrow infiltration at times cannot be assessed reliably from hemogram findings only and a bone marrow biopsy for staging is mandatory